Article • medical-pharmaceutical-robots
Enovis to Acquire Surgical Robotics Provider eCential Robotics for $180M

Enovis Corp., a global medical technology company, has entered into a binding offer to acquire eCential Robotics for approximately $180 million, marking a strategic move to expand its orthopedic robotics capabilities.
The acquisition brings eCential's open, modular surgical robotics platform for bone surgery into Enovis' ASTRA technology ecosystem, which the company describes as a "constellation of technologies and services" for orthopedics.
Gières, France-based eCential brings over 15 years of innovation in computer-assisted surgery and orthopedic robotics, with its technology already deployed in spine and knee procedures.
Damien McDonald, CEO and Director of Enovis, stated:
"As the market and customer demands continue to evolve, it has become clear that providing surgeons with optionality across the enabling technology spectrum is important. Supplementing our existing platform by providing a robotic solution will only accelerate our position in the market and broaden our strategic options as we innovate in this space in the future."
Enovis plans to pay €176 million ($204.3 million) to eCential shareholders at closing, plus up to €35 million ($40.6 million) in contingent consideration upon achieving certain milestones, with the transaction expected to close by the end of 2026.
Clément Vidal, CEO of eCential Robotics, stated:
"Our strategy at eCential Robotics has always been to offer surgeons easy-to-use, cutting-edge technology to improve surgical workflows, and ultimately, enable better patient outcomes. As part of Enovis, we will be able to grow through a shared mission to support surgeons with greater operating room efficiency, and help patients live more full, active lives."
McDonald emphasized that the acquisition extends beyond hardware, bringing talent, intellectual property, and advanced capabilities. The company plans to bring a next-generation robot to market within two years, initially targeting knee procedures followed by shoulder applications, leveraging eCential's seven-degrees-of-freedom robotic arm and proprietary control software.
Related Articles
More articles →
medical-pharmaceutical-robots
MMI Raises $125 Million in Series D to Accelerate Symani Surgical System Growth

medical-pharmaceutical-robots
Stryker Launches Mako 4 SmartRobotics in India for Robotic-Assisted Joint Replacement

medical-pharmaceutical-robots